Unique ID issued by UMIN | C000000360 |
---|---|
Receipt number | R000000446 |
Scientific Title | A randomized controlled trial to evaluate the effectiveness of adjuvant chemotherapy using FOLFOX to prevent recurrence after curative radiofrequency ablation of liver metastasis from colorectal carcinoma |
Date of disclosure of the study information | 2006/06/01 |
Last modified on | 2013/09/17 08:17:02 |
A randomized controlled trial to evaluate the effectiveness of adjuvant chemotherapy using FOLFOX to prevent recurrence after curative radiofrequency ablation of liver metastasis from colorectal carcinoma
A randomized controlled trial for adjuvant FOLFOX therapy after radiofrequency ablation of liver metastasis from colorectal carcinoma.
A randomized controlled trial to evaluate the effectiveness of adjuvant chemotherapy using FOLFOX to prevent recurrence after curative radiofrequency ablation of liver metastasis from colorectal carcinoma
A randomized controlled trial for adjuvant FOLFOX therapy after radiofrequency ablation of liver metastasis from colorectal carcinoma.
Japan |
Cases with liver metastasis from colorectal carcinoma, which is removed curatively by radiofrequency ablation
Gastroenterology | Hepato-biliary-pancreatic medicine |
Malignancy
NO
To evaluate the effectiveness of FOLFOX as adjuvant chemotherapy to prevent recurrence after curative ablation of liver metastasis from colorectal carcinoma, by comparing the disease-free survivals between RFA alone and RFA with adjuvant therapy.
Efficacy
Exploratory
Pragmatic
Liver metastasis disease-free survival
Disease-free survival
Overall survival
Side effect
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
YES
YES
Institution is considered as adjustment factor in dynamic allocation.
NO
Central registration
2
Treatment
Medicine |
Parenterally administration of mFOLFOX6 for 12 courses after curative radoiofrequency ablation of liver metastasis from colorectal carcinoma
Only follow-up without any anti-cancer therapy after curative radiofrequency ablation of liver metastasis from colorectal carcinoma
20 | years-old | <= |
Not applicable |
Male and Female
Patients undergoing curative radiofrequency ablation for liver metastasis (max 5cm and 5 nodules) from colorectal carcinoma. No residual disease by CT or MRI image after radiofrequency ablation and no disease except for liver metastasis and the primary colorectal carcinoma is resected.
The patients with other malignant disease, non-curative radiofrequency ablation
190
1st name | |
Middle name | |
Last name | Masao Omata |
Tokyo University Hospital
Deoartment of gastroenterology
7-3-1, Hongo, Bunkyo-ku, Tokyo
03-3815-5411
1st name | |
Middle name | |
Last name |
Tokyo University Hospital
Deoartment of gastroenterology
7-3-1, Hongo, Bunkyo-ku, Tokyo
03-3815-5411
Department of gastroenterology,
Tokyo University Hospital
The Ministry of Education, Science, Sports and Culture.
NO
2006 | Year | 06 | Month | 01 | Day |
Unpublished
Completed
2006 | Year | 02 | Month | 08 | Day |
2006 | Year | 04 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2011 | Year | 03 | Month | 01 | Day |
2006 | Year | 03 | Month | 15 | Day |
2013 | Year | 09 | Month | 17 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000446
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |